The overall goal of this P41 center is to disseminate optimal new hyperpolarized (HP) 13C MR technologies with optimal training/documentation to advance significantly this emerging molecular imaging method. Through our HP MR studies to date, it has become clear both that hyperpolarized 13C MR has outstanding research and clinical value, but also that virtually all aspects of this technology (instrumentation, agent chemistry, DNP/dissolution methodology, MR acquisition, and data analysis) are currently suboptimal and require focused technological development to realize their full potential. This center includes three Technology Research & Development (TR&D) projects led by experienced hyperpolarized MR researchers. All TR&D developments are driven in a push-pull manner by 10 independently NIH-funded Collaborative Projects (CP's) and the technology resources of the center will be utilized by 8 Service Projects (SP's) and disseminated to all interested investigators through hands-on workshops, visits, email, and via the HMTRC website. TR&D1, led by the PI Dr. Vigneron, is focused on DNP polarizer and MR acquisition development for pre-clinical animal studies and their translation for future human studies. TR&D2 led by Dr. Kurhanewicz focuses on the development of new robust and realistic pre-clinical models for HP MR studies, optimization of current HP probes & investigation of new HP probes, and the development of methods that provide appropriate correlative pathologic, biologic and other imaging data for understanding and validating HP MR findings. TR&D3 led by Dr. Nelson focuses on enhancing a free open-source specialized software platform for HP MR data reconstruction and visualization. In its first four years, the HMTRC has developed new polarization, MR acquisition, bioreactor, and analysis techniques driven by close interactions with the CP projects resulting in 70 publications and over 150 conference presentations. This BTRC has also spawned/supports currently more than 15 NIH grants including new ones for all 10 proposed CP's. Guided by an exceptional EAC, the HMTRC has created an extensive infrastructure that extends nationally and internationally to support the SP's and other collaborators, a new website, highly successful hands-on workshops, and other focused training and dissemination activities. Since the submission of the current P41, the first Phase 1 clinical trial in prostate cancer patients was conducted and demonstrated safety and feasibility of this emerging molecular imaging technique. Now, four of the Collaborative Projects include future human studies. Therefore we are modifying the structure and goals of the center to not only advance preclinical HP MR, but also to include new technology development, administrative infrastructure, training and dissemination to support and advance future human studies at UCSF and other institutions.

Public Health Relevance

Hyperpolarized MR is a new molecular imaging method to monitor enzymatic conversions through key, previously-inaccessible biochemical pathways. Therefore this center project aims to collaboratively develop new technology to advance this field in order to better identify and understand human disease and ultimately to translate and disseminate these techniques for improved patient care.

National Institute of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Biotechnology Resource Grants (P41)
Project #
Application #
Study Section
Special Emphasis Panel (ZEB1)
Program Officer
Liu, Guoying
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Schools of Medicine
San Francisco
United States
Zip Code
Mutch, Christopher A; Ordonez, Alvaro A; Qin, Hecong et al. (2018) [11C]Para-Aminobenzoic Acid: A Positron Emission Tomography Tracer Targeting Bacteria-Specific Metabolism. ACS Infect Dis 4:1067-1072
Jiang, Wenwen; Larson, Peder E Z; Lustig, Michael (2018) Simultaneous auto-calibration and gradient delays estimation (SAGE) in non-Cartesian parallel MRI using low-rank constraints. Magn Reson Med 80:2006-2016
von Morze, Cornelius; Ohliger, Michael A; Marco-Rius, Irene et al. (2018) Direct assessment of renal mitochondrial redox state using hyperpolarized 13 C-acetoacetate. Magn Reson Med 79:1862-1869
Park, Ilwoo; Larson, Peder E Z; Gordon, Jeremy W et al. (2018) Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn Reson Med 80:864-873
Autry, Adam W; Hashizume, Rintaro; James, C David et al. (2018) Measuring Tumor Metabolism in Pediatric Diffuse Intrinsic Pontine Glioma Using Hyperpolarized Carbon-13 MR Metabolic Imaging. Contrast Media Mol Imaging 2018:3215658
Axler, Sheldon; Shin, Peter J (2018) THE NEUMANN PROBLEM ON ELLIPSOIDS. J Appl Math Comput 57:261-278
von Morze, Cornelius; Merritt, Matthew E (2018) Cancer in the crosshairs: targeting cancer metabolism with hyperpolarized carbon-13 MRI technology. NMR Biomed :e3937
Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408
Li, Nan; Liu, Shengping; Hu, Xiaoqing et al. (2018) Electromagnetic Field and Radio Frequency Circuit Co-Simulation for Magnetic Resonance Imaging Dual-Tuned Radio Frequency Coils. IEEE Trans Magn 54:
Sriram, Renuka; Sun, Jinny; Villanueva-Meyer, Javier et al. (2018) Detection of Bacteria-Specific Metabolism Using Hyperpolarized [2-13C]Pyruvate. ACS Infect Dis 4:797-805

Showing the most recent 10 out of 129 publications